Key takeaways
- Isotretinoin is used for severe, resistant acne; it is not a cosmetic oil-control supplement. South African Acnetane leaflet.
- A lower prescribed dose does not make isotretinoin safe in pregnancy. SAHPRA-hosted pregnancy warning.
- Treatment should include discussion and follow-up of mental health and sexual-function concerns. MHRA safety review.
- The amount and duration of treatment are individual decisions, not a regimen to copy from another person’s prescription. Acnetane patient information.
The South African Acnetane leaflet describes a first course lasting 4 to 8 months, depending on the prescribed daily amount. It says improvement can continue after treatment stops and that, if acne relapses, a further course should not begin until at least 8 weeks after the first. “Low dose” does not specify how long treatment will last or remove its precautions. Acnetane treatment information.
Does a lower dose mean fewer risks?
A lower-dose plan may be chosen to improve tolerability, but it does not remove serious precautions or guarantee clearance.
Acnetane prescriptions are based on body weight. The doctor may change the amount according to response or side effects. The leaflet lists dry lips, dry skin, a dry nose and nosebleeds among frequent effects. It gives no assurance of “virtually no side effects” or an indefinitely safe maintenance regimen. Acnetane leaflet.
| Question | What to clarify with the prescriber |
|---|---|
| Why this approach? | Acne severity, previous treatment and tolerability |
| How will benefit be judged? | New lesions, scarring risk and your own treatment goals |
| How long might treatment last? | The planned review points, not a fixed online schedule |
| What stays essential? | Pregnancy precautions, safety assessment and follow-up |
A lower prescribed amount still needs the planned reviews. Dryness alone cannot show whether the course is safe or whether acne will clear.
What remains essential around pregnancy?
Isotretinoin must not be used during pregnancy, and pregnancy-prevention requirements still apply to lower-dose treatment.
The local leaflet requires two reliable contraception methods for patients who could become pregnant, starting one month before treatment and continuing until one month after stopping. It describes a pregnancy test 2 weeks before treatment and possible further tests during the course. The prescriber must explain these requirements and obtain the signed consent form before treatment. If pregnancy is suspected, stop taking isotretinoin and contact the prescriber urgently. Local patient information.
Ask for the patient leaflet, birth-control brochure and consent form listed in the Acnetane instructions. Tell the clinician about pregnancy plans and breastfeeding. The leaflet also prohibits blood donation during treatment and for 30 days afterwards, to prevent a pregnant recipient being exposed. Never share leftover capsules. Pregnancy precautions.
What should follow-up cover besides your skin?
Appointments should address wellbeing and side effects as well as acne improvement.
The MHRA collected information from patients, families and clinicians about suspected psychiatric and sexual effects, including symptoms continuing after treatment. Its public call received 710 complete responses, of which 659 provided views. Those responses informed an expert review; they are not a measure of how often side effects occur. The resulting recommendations emphasise assessment and monitoring. UK administrative prescribing requirements apply in the UK, while this article uses the review as safety evidence for South African readers. MHRA review.
Tell the prescriber about new depression, anxiety, changes in sexual function or other symptoms that concern you. Thoughts of self-harm need immediate emergency support. Do not wait for your skin to improve before asking for help.
Acnetane’s listed side effects include raised liver enzymes and changed blood-fat levels, including triglycerides. Your clinician sets the blood tests and review frequency. A normal early result does not establish that later monitoring is unnecessary. Laboratory effects.
How can you prepare for the next appointment?
Bring a symptom record and the names of your medicines, supplements and skin products.
Write down when symptoms began and any effect on sleep, exercise or contact-lens wear. Acnetane lists joint, back and muscle pain. For dry eyes, the leaflet suggests lubricating eye solution or spectacles in place of contact lenses.
Ask which symptoms need a same-day call. For rash with fever, blisters, peeling skin or mouth sores, the leaflet’s instruction is to stop Acnetane and contact the doctor immediately. These can be signs of a serious skin reaction. Side effects and eye care.
Do not have wax hair removal while taking Acnetane or for 6 months afterwards. Do not use exfoliating acne preparations during the course. The leaflet permits mild topical products on the doctor’s recommendation and prohibits vitamin A supplements, including multivitamins containing it. Acnetane skin-care precautions.
For topical treatment questions, see the tretinoin strength guide. For marks left after inflammation, read the hydroquinone and pigmentation guide. Ask before adding either product during isotretinoin treatment. Acnetane interactions.
Do and don’t
Do:
- Keep follow-up appointments and the written safety instructions.
- Check the ingredient against your prescription: Accutane and Acnetane are isotretinoin brand names.
- Raise mood or sexual symptoms directly, even if discussing them feels awkward.
Don’t:
- Start a low-dose course from an online schedule.
- Treat fewer dry-skin symptoms as proof that pregnancy precautions no longer matter.
